NTRK1 and lung adenocarcinoma: LSQCCs are characterized by frequent mutations of TP53 and CDKN2A alterations; EGFR alterations are less frequent in LSCCC than in lung adenocarcinoma and actionable mutations in receptor tyrosine kinases are rarely observed in LSQCC.